Sendero Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-11,219
Closed -$479K – 211
2026
Q2
$479K Sell
11,219
-86
-0.8% -$4.67K 0.05% 162
2026
Q1
$709K Buy
+11,305
New +$904K 0.08% 136
2024
Q2
– Sell
-35,767
Closed -$2.45M – 158
2024
Q1
$2.45M Sell
35,767
-506
-1% -$32.5K 0.42% 50
2023
Q4
$2.1M Sell
36,273
-9
-0% -$480 0.4% 51
2023
Q3
$1.92M Buy
36,282
+1,817
+5% +$95.3K 0.41% 50
2023
Q2
$1.86M Sell
34,465
-17,333
-33% -$905K 0.41% 52
2023
Q1
$2.59M Sell
51,798
-7,059
-12% -$333K 0.79% 27
2022
Q4
$2.72M Buy
58,857
+713
+1% +$30.9K 0.97% 14
2022
Q3
$2.25M Buy
58,144
+3,240
+6% +$130K 0.94% 14
2022
Q2
$2.05M Buy
+54,904
New +$2.23M 1.96% 9
2022
Q1
– Sell
-30,881
Closed -$1.31M – 81
2021
Q4
$1.31M Buy
+30,881
New +$1.3M 0.58% 29

Other funds holding BSX

Sendero Wealth Management's BSX Position: Q3 2026 in Review

Sendero Wealth Management sold out of Boston Scientific (BSX) in Q3 2026, closing a stake of 11,219 shares — an estimated $479K sold.

Sendero Wealth Management first reported a position in BSX in Q4 2021 and held it in 11 quarters. The position peaked at $2.72M in Q4 2022. 1,512 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Sendero Wealth Management reported no remaining Boston Scientific position as of Q3 2026 after selling out during the quarter.
  • Sendero Wealth Management sold 11,219 Boston Scientific shares in Q3 2026, an estimated $479K.
  • Sendero Wealth Management first reported a position in Boston Scientific in Q4 2021 and held it in 11 quarters.
  • Sendero Wealth Management's Boston Scientific position peaked at $2.72M in Q4 2022.
  • 1,512 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Sendero Wealth Management's 13F filing for Q3 2026, filed 14 Oct 2026.